We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $7.48B
1-Year Est. Return 104.76%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$6.05B
AUM Growth
-$355M
Cap. Flow
-$238M
Cap. Flow %
-3.93%
Top 10 Hldgs %
22.18%
Holding
314
New
46
Increased
155
Reduced
70
Closed
36

Top Buys

Rank Stock Value
1
WGS icon
GeneDx Holdings
WGS
+$41.9M
2
GNRC icon
Generac Holdings
GNRC
+$40.9M
3
PCVX icon
Vaxcyte
PCVX
+$24.8M
4
TER icon
Teradyne
TER
+$24.8M
5
ULS icon
UL Solutions
ULS
+$21.1M

Top Sells

Rank Stock Value
1
MIRM icon
Mirum Pharmaceuticals
MIRM
+$64.4M
2
GEV icon
GE Vernova
GEV
+$42.1M
3
INSP icon
Inspire Medical Systems
INSP
+$40.6M
4
RNAM
Avidity Biosciences
RNAM
+$37.8M
5
LAD icon
Lithia Motors
LAD
+$33.8M

Sector Composition

Rank Sector Weight
1 Healthcare 39.12%
2 Industrials 19.41%
3 Technology 15.63%
4 Energy 7.14%
5 Consumer Discretionary 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SO icon
151
Southern Company
SO
$102B
$6.81M 0.11%
70,433
-40,409
-36% -$3.74M
EHC icon
152
Encompass Health
EHC
$11.8B
$6.81M 0.11%
70,302
+1,334
+2% +$137K
HELP
153
Cybin Inc
HELP
$923M
$6.77M 0.11%
1,410,815
+153,815
+12% +$995K
RLMD icon
154
Relmada Therapeutics
RLMD
$476M
$5.86M 0.1%
+842,106
New +$3.98M
MU icon
155
Micron Technology
MU
$1.06T
$5.84M 0.1%
17,852
+8,879
+99% +$3.48M
SPGI icon
156
S&P Global
SPGI
$130B
$5.82M 0.1%
13,762
-13,233
-49% -$6.14M
EVH icon
157
Evolent Health
EVH
$525M
$5.81M 0.1%
+2,547,558
New +$8.08M
ENB icon
158
Enbridge
ENB
$110B
$5.64M 0.09%
103,721
-24,428
-19% -$1.24M
CDNS icon
159
Cadence Design Systems
CDNS
$93.9B
$5.48M 0.09%
19,851
+3,043
+18% +$908K
DUK icon
160
Duke Energy
DUK
$94.6B
$5.2M 0.09%
39,512
-7,320
-16% -$915K
ANET icon
161
Arista Networks
ANET
$248B
$5.05M 0.08%
41,617
-17,041
-29% -$2.28M
COP icon
162
ConocoPhillips
COP
$156B
$4.98M 0.08%
37,447
+443
+1% +$49.1K
AEP icon
163
American Electric Power
AEP
$67.2B
$4.85M 0.08%
36,957
+15,922
+76% +$1.99M
EWTX icon
164
Edgewise Therapeutics
EWTX
$4.73B
$4.72M 0.08%
149,863
-418,447
-74% -$12.1M
BBOT
165
BridgeBio Oncology
BBOT
$711M
$4.7M 0.08%
541,181
-541,181
-50% -$5.81M
LLY icon
166
Eli Lilly
LLY
$1.05T
$4.62M 0.08%
5,121
+425
+9% +$431K
RF icon
167
Regions Financial
RF
$26B
$4.61M 0.08%
182,634
-22,522
-11% -$629K
TRP icon
168
TC Energy
TRP
$64.6B
$4.3M 0.07%
+67,377
New +$4.06M
SYK icon
169
Stryker
SYK
$125B
$4.28M 0.07%
13,095
+4,510
+53% +$1.62M
CTMX icon
170
CytomX Therapeutics
CTMX
$730M
$4.23M 0.07%
+900,000
New +$4.57M
NOW icon
171
ServiceNow
NOW
$147B
$3.67M 0.06%
35,055
-32,980
-48% -$3.88M
UNP icon
172
Union Pacific
UNP
$183B
$3.51M 0.06%
14,577
+6,044
+71% +$1.48M
AMD icon
173
Advanced Micro Devices
AMD
$776B
$3.32M 0.05%
16,526
-2,139
-11% -$457K
SAP icon
174
SAP
SAP
$256B
$3.09M 0.05%
18,154
+6,033
+50% +$1.25M
VLO icon
175
Valero Energy
VLO
$100B
$3.03M 0.05%
12,089
+4,698
+64% +$969K
5 6
7
8 9

Similar funds

S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $7.52B AUM 15.3% 1-Year Est. Return
O
Ossiam Paris, France $7.54B AUM 50.81% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.41B AUM 26.32% 1-Year Est. Return
RIG
RiverFront Investment Group Richmond, Virginia $7.56B AUM 23.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

Eventide Asset Management's Q1 2026 Portfolio in Review

As of Q1 2026, Eventide Asset Management held 314 positions worth $6.05B, down 5.5% from $6.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Eventide Asset Management withdrew a net $238M in Q1 2026, closing 36 positions and reducing 70 holdings. Its most notable exit was Inspire Medical Systems, an estimated $40.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 42% a quarter earlier, followed by Industrials and Technology.

Against the trend, Eventide Asset Management opened a new position in GeneDx Holdings worth $29.5M.

  • Eventide Asset Management's largest Q1 2026 buy was GeneDx Holdings: 459,015 shares worth $29.5M.
  • Eventide Asset Management added most to Generac Holdings in Q1 2026, an estimated $40.9M increase.
  • Eventide Asset Management's biggest Q1 2026 reduction was Mirum Pharmaceuticals, cutting an estimated $64.4M.
  • Eventide Asset Management fully exited Inspire Medical Systems in Q1 2026, selling an estimated $40.6M.
  • Eventide Asset Management's ten largest holdings make up 22% of its $6.05B portfolio in Q1 2026.
  • Eventide Asset Management opened 46 new positions and closed 36 in Q1 2026.
  • Eventide Asset Management's portfolio value fell 5.5% quarter-over-quarter to $6.05B.

Based on Eventide Asset Management's 13F filing for Q1 2026, filed 15 May 2026.